Shared Decision Making in Low Risk Prostate Cancer
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/30/2017 |
| Start Date: | August 2012 |
Shared Decision Making: A Study Assessing the Benefit of a Web Based Aid Presenting Treatment Options for Patients With Low Risk Prostate Cancer
This study will evaluate the usefulness of an informational website designed to educate
patients with prostate cancer about their options for treatment. The investigators hope that
this website will assist patients with making informed decisions about their care and
improving their satisfaction with the treatments they choose.
patients with prostate cancer about their options for treatment. The investigators hope that
this website will assist patients with making informed decisions about their care and
improving their satisfaction with the treatments they choose.
Investigators will first ask patients to answer a series of questions to assess their wishes
regarding treatment, knowledge about their disease and discussion with the physicians at
initial patient visit. This initial survey should take approximately 20 minutes. Once
patients have selected a treatment path investigators will contact them again and ask them to
fill out a short 10-minute survey online or by mail. Investigators will contact patients by
phone 2 weeks after their initial visit to see if they have made a decision. If not,
investigators will contact patients by phone every 2 weeks or at an interval that works for
the patient's schedule. Finally, 3 months after the initial visit today investigators will
contact patients for the last time and again ask you to fill out a short 10-minute survey
online or by mail.
Once patients have completed the final survey there are no future surveys planned.
Investigators may contact patients by phone in the future to ask them to participate in
another study.
regarding treatment, knowledge about their disease and discussion with the physicians at
initial patient visit. This initial survey should take approximately 20 minutes. Once
patients have selected a treatment path investigators will contact them again and ask them to
fill out a short 10-minute survey online or by mail. Investigators will contact patients by
phone 2 weeks after their initial visit to see if they have made a decision. If not,
investigators will contact patients by phone every 2 weeks or at an interval that works for
the patient's schedule. Finally, 3 months after the initial visit today investigators will
contact patients for the last time and again ask you to fill out a short 10-minute survey
online or by mail.
Once patients have completed the final survey there are no future surveys planned.
Investigators may contact patients by phone in the future to ask them to participate in
another study.
Inclusion Criteria:
- Histologically confirmed prostate adenocarcinoma
- Internet access
- Able to read and understand English
Exclusion Criteria:
- Evidence of nodal metastases
- Evidence of distant metastases
- Prior surgery, chemotherapy, pelvic radiation or prostate brachytherapy for prostate
cancer
We found this trial at
1
site
Click here to add this to my saved trials
